Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome Academic Article uri icon

Overview

MeSH Major

  • Bifidobacterium
  • Irritable Bowel Syndrome
  • Probiotics

abstract

  • B. infantis 35624 is a probiotic that specifically relieves many of the symptoms of IBS. At a dosage level of 1 x 10(8) cfu, it can be delivered by a capsule making it stable, convenient to administer, and amenable to widespread use. The lack of benefits observed with the other dosage levels of the probiotic highlight the need for clinical data in the final dosage form and dose of probiotic before these products should be used in practice.

publication date

  • July 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1572-0241.2006.00734.x

PubMed ID

  • 16863564

Additional Document Info

start page

  • 1581

end page

  • 90

volume

  • 101

number

  • 7